Mangoceuticals, Inc. SEC filings MGRX

Mangoceuticals, Inc. has 240 filings in SEC EDGAR's recent list, going back to Aug 31, 2022. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (material agreement). The company's fiscal year ends on December 31.

Mangoceuticals, Inc. SEC filings
Form Description Filed Period
10-K Annual report Apr 1, 2026 Dec 31, 2025
10-K Annual report Mar 20, 2025 Dec 31, 2024
ARS Annual report to shareholders May 16, 2024 Dec 31, 2023
10-K Annual report Apr 1, 2024 Dec 31, 2023

Showing 4 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
MGRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
TX
Headquarters
Dallas, TX
SEC filer status
, Emerging growth company
SEC CIK
1938046
Former names
MANGOCEUTICALS, INC. (until Oct 9, 2026)

Other Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.